STAT3 and breast cancer: Liposomal nanoparticles (NPTs) containing hydrazinocurcumin, a synthetic analog of curcumin, were used to suppress STAT3 activity in M2-like TAMs in a breast cancer model, re-educating TAM to M1 phenotype and restoring the crosstalk with tumor cells.